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!!!!!! !!
Figure S1, Related to Figure 1 
A) FACS sorted Lin-CD127+CD90.2+NKP46- gated cells in the primary tumor express 
additional markers CCR6, CD4 and ROR!T that define LTi/ILC3.  B) Immunofluorescence of 
unsorted CD11c-depleted splenocytes. An ILC3 cell (white arrow) is seen amongst CD3+ cells. 
Bottom panel demonstrated that majority of the sorted cells express the nuclear transcription 
factor ROR!T. 
!!!!
Figure'S2,'Related'to'Figure'2'
 
A: Protein levels of CXCL13 and CCL21 in conditioned media (CM) obtained from the bone 
marrow derived MSC cell line (HS-5) compared to non-conditioned media were measured by 
ELISA. MSC cells seeded at densities of either 6x103 or 12x103 cells per well are shown above. 
Data represent means of three independent experiments ± SEM. B & C: ELISA quantification 
of CXCL13 and CCL21 chemokine levels in the conditioned media from the breast cancer cell 
line 4T1.2 cell line is shown. Positive control = murine stromal cell line (ST2s); Negative 
control = media alone.   Asterisks represent the p-values when comparing to the control groups 
(one-way ANOVA; ** p≤0.01). !!!!!!!!!!!!
!!
Figure S3, Related to Figure 2 
A:'ILC3!cells!do!not!proliferate!when!co5cultured!with!human!MSCs.!FACS5sorted!ILC3!cells!were!labelled!with!an!eFluor450!cell!tracker!dye!and!co5cultured!with!human!HS55!MSC!cell!line!(ratio!10:1,!ILC3:MSC)!for!48h.!As!proliferation!positive!control,!cell5tracker!dye5labelled! splenocytes! were! stimulated! with! plate5bound! anti5CD3! (1! µg/ml)! and!soluble!anti5CD28!(2!µg/ml)!antibodies.!At!the!end!of!the!co5culture!cells!were!stained!with!a!viability!dye!and!analysed!by!flow!cytometry.!!B and C: MSC cells were transfected 
with non targeting (NT) control or siRNAs  specific for CXCL13 or CCL21 (CXCL13 siRNA: 
si-20725, si-20726, si-20727 or CCL21 siRNA: si-12605, si-12606, si-12607 etc respectively). 
Cell culture supernatents were analyzed by ELISA at 48hours (* p≤0.05, ** p≤0.01, paired t-
test). 
!!!!!
Figure S4, Related to Figure 4 
 
A: CXCR5 expression on MSC cells. The histograms show the expression of CXCR5 on HS-
5 human MSC cell line and human peripheral blood B-cells (positive control) as compared to 
control isotype antibody. The graph on the left shows cumulative data from three different 
experiments. !!!!!!!!!!!!!!!!!
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Figure S5, Related to Figure 5 
Expression of lymphoid chemokine and chemokine receptor genes in breast cancer 
datasets. Heat maps display gene-standardised expression for each breast cancer data set. 
Columns (samples) are ordered by increasing expression score (mean of gene standardised 
expression values of the listed genes) and displayed in blocks representing score quintiles (left-
right, lowest to highest expression score). PAM50 assignments are depicted above. Bar plots 
show the distribution of intrinsic subtype assignments within each expression quintile. Relative 
enrichment for the basal-like subtype (red) amongst samples with higher expression scores is 
observed in multiple independent data sets. 
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Figure S6, Related to Figure 5 
Breast cancer tissue with prominent tertiary lymphoid follicle formation. Tumor infiltrating 
lymphocytes are not only scattered throughout the stroma and interspersed between tumor 
cells; they also cluster in aggregates resembling tertiary lymphoid tissue with distinct 
compartmentalization between a T and a B cell zone. A: H&E histopathological images show 
(A): Low power view of a breast cancer tumour section and (B): High power view allows 
identification of dense areas of lymphoid cell aggregates within the human breast cancer 
microenvironment (red circles). C: Immunofluorescence for CD3 (membrane or cytoplasmic 
blue staining) identifies the outer T-zone of these lymphoid structures. D: Identification of a 
ROR!T+CD127+CD3- ILC3 cells (white arrow) (ROR!T+, green nuclear; CD127+, red 
perinuclear) within the TLS. TZ=T zone. Red squares represent areas of interest.  
 
!Video S1, Related to Figure 2!
 
Time lapse microscopy experiment of sorted NKp46-ILC3 cells (CD3-, CD11c-, B220, NKp46-
, CD127+, CD90.2+) co-cultured with MSC cells as described in Figure 2B.  Low magnification 
(×10) video shows the general clustering pattern of NKp46-ILC3 cells around the MSC cells 
over a duration of 10 hours.  Experimental conditions were as described in Figure 2B legend 
and in more detail in Experimental Procedures.  
 
Video S2, Related to Figure 2 
Time lapse microscopy experiment of sorted NKp46-ILC3 cells (CD3-, CD11c-, B220-, NKp46-
, CD127+, CD90.2+) co-cultured with MSC cells as described in Figure 2B.  High magnification 
(×40) video shows the prolonged interaction of NKp46-ILC3 and MSC cells upon contact. 
Experimental conditions were as described in Figure 2B legend and in more detailed in 
Experimental Procedures.  
 
Supplementary Methods 
 
Immunohistochemistry, Immunofluorescence and Image analysis 
Immunohistochemistry of formalin-fixed, paraffin-embedded sections for podoplanin was performed 
on the Leica BOND-Max automated IHC platform (Leica Microsystems Inc, Wetzlar, Germany). 
Sections were incubated with monoclonal podoplanin antibody (18H5, diluted 1:1500 from Abcam, 
Cambridge, UK), and antigen binding detected using the Leica BOND refine polymer detection kit, 
DS9800. For immunohistochemistry of pan-cytokeratin, frozen sections were fixed in acetone and 
incubated with HRP-conjugated monoclonal pan-cytokeratin antibody (C11, diluted 1:500 from Santa 
Cruz Biotechnology, Santa Cruz, USA). Antigen binding was detected using ImmPACT DAB 
peroxidase substrate (Vector Labs, Burlingame, USA). Stained sections were photographed using a 
Hamamatsu NanoZoomer-XR C12000 digital slide scanner (Hamamatsu Photonics; Japan) and staining 
areas were quantified using its integrated software. 
For immunostaining of RANKL, cells were fixed (4% paraformaldehyde, 10 min), permeabilized 
(0.25% TritonX-100, 12 min at RT), blocked (1% BSA, 30 min) and incubated with the primary 
antibodies diluted in blocking solutions (see Table S2), followed by several washes with PBS and 
incubation with an suitable fluorescently conjugated secondary antibodies. 
 
Time-lapse microscopy and image analysis 
To measure the NKp46-ILC3 clustering around stromal cells, series of image processing functions in 
ImageJ were performed to measure the area of the frame occupied by the cells. AVI videos were 
recorded in an RGB format and then converted to 8-bit grey-scale. Each frame of the video was treated 
independently and a 2-D rolling ball algorithm (aka grey-scale morphology) was run using the "Subtract 
Background" function with a ball radius of 10 pixels to remove interfering background variations. The 
Otsu algorithm ("Auto Threshold", "method = Otsu white"), was used to segment the foreground cells 
from the background by thresholding. On the resulting binary image the "Measure" function reports the 
average image intensity. This value divided by 255 equals the area proportion of foreground in the 
frame, for a binary image, and this was used to quantify the clustering. This algorithm has been 
implemented as an ImageJ macro running in batch mode, with a processing time of about 7 min for one 
300-frame video. The macro is available from 
(http://users.ox.ac.uk/~atdgroup/software/ForegroundArea_batch.ijm). 
 
ELISA  
Tumors were snap frozen and lysed by homogenisation in 100mM Tris pH 7.5, 150mM NaCl, 1mM 
EGTA, 1mM EDTA, 1% (v/v) Triton-X-100 and 0.5% (w/v) sodium deoxycholate. ELISAs were 
performed using commercially available DuoSet kits (R&D Systems, Minneapolis, USA). 
  
Supplementary Table S1:  List of antibodies used  
Name Clone Dilution Company Cross-
reactivity 
to MS 
Cross-
reactivit
y to Hu 
Rat anti-human ROR!t AFKJ5-9 1:25 Ebioscience Yes Yes 
Mouse anti-human CD127 Biotin ebioRDR5 1:25 Ebioscience No Yes 
Mouse anti-human CD3 APC UCHT1 1:30 Ebioscience No Yes 
Dnk anti-Rat-IgG-FITC - 1: 100 Jackson ImmunoResearch Minimal Minimal 
Rabbit anti-rat IgG-FITC - 1:200 Invitrogen No No 
Goat anti-Rabbit-FITC - 1:100 Southern Biotech No No 
Streptavidin Alexa 555 - 1:500 Invitrogen No No 
Mouse Anti-human gp36/podoplanin 18H5 1:1500 Abcam No Yes 
Armenian Hamster anti-mouse CD3e-PE 145-2C11 1:200 Ebioscience Yes  No 
Armenian Hamster anti-mouse CD11c-FITC N418 1:100 Miltenyi Biotec Yes  No 
Rat anti-mouse B220/CD45R- Alexa Flour® 646 RA3-6B2 1:150 Biolegend® Yes  No 
Rat anti-mouse CD127 (IL-7Ra)-PerCP/Cy5.5 A7R34 1:50 Biolegend® Yes  No 
Rat anti-mouse CD90.2-APC/Cy7 30-H12 1:50 Biolegend® Yes  No 
Rat anti-mouse CD335 (NKp46) eFluor® 450 29A1.4 1:100 ebioscience Yes  No 
Rabbit anti-human/mouse RANK - 1:1000 Cell Signaling Yes Yes  
Goat anti-mouse RANKL - 1:500 R&D Yes No 
Goat anti-mouse Pancytokeratin - 1:500 Santa Cruz Yes Yes 
 
 
  
Supplementary Table S2: Sequence of siRNA oligonucleotides  
 
Gene  SiRNA ID Target Sequence (5’ -> 3’) 
CXCL13 S20727 CAAGCUGAAUGGAUACAAA 
CXCL13 S20726 UGAUGGAAGUAUUGAGAAA 
CXCL13 S20725 AUCGAAUUCAAAUCUUGGU 
CCL21 S12606 CCAUCCCAGUAUCCUGUU 
CCL21 S12605 CAGCUACCGAAGCAGGAA 
CCL21 S12607 GCTATCCTGTTCTTGCCCCG 
Scrambled #10300934 Non-targeting siRNA pool from Thermo Scientific Dharmacon 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                     
Table S1, Related to Figure 5 
Table S1:  Clinico-pathological characteristics for the METABRIC sample.  
(i)! Guy's METABRIC gene expression data set.  Poor quality arrays were filtered 
out, leaving 234 out of a possible 250 samples for analysis for lymphoid gene 
expression analysis. 
(ii)!  Guy's METABRIC gene expression data set stained for ILC3 density data (n=59). 
